APA (7th ed.) Citation

Dutertre, M., de Menthon, M., Noël, N., Albiges, L., & Lambotte, O. (2019). Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab. European Journal of Cancer, 110, 21. https://doi.org/10.1016/j.ejca.2019.01.009

Chicago Style (17th ed.) Citation

Dutertre, Martin, Mathilde de Menthon, Nicolas Noël, Laurence Albiges, and Olivier Lambotte. "Cold Agglutinin Disease as a New Immune-related Adverse Event Associated with Anti-PD-L1s and Its Treatment with Rituximab." European Journal of Cancer 110 (2019): 21. https://doi.org/10.1016/j.ejca.2019.01.009.

MLA (9th ed.) Citation

Dutertre, Martin, et al. "Cold Agglutinin Disease as a New Immune-related Adverse Event Associated with Anti-PD-L1s and Its Treatment with Rituximab." European Journal of Cancer, vol. 110, 2019, p. 21, https://doi.org/10.1016/j.ejca.2019.01.009.